General Introduction to Pricing
FIND is bound and conforms to Global Health Access terms and conditions, which aim at equitable access for people in resource poor environments who are most in need. In particular, these terms require access to products and services at affordable pricing. FIND has established a number of agreements with diagnostics suppliers for preferential pricing for the Public Sector in Low and Middle income countries (as defined by the World Bank). This preferential pricing is based on Ex-works prices which can be accessed via the specific supplier directly as listed under the product specific details on this FIND site. The definition of the Public Sector as applied to the preferential pricing is given at the end of this section.
Notwithstanding these general terms, the intention of the preferential pricing model is, of course, to have an affordable price for the patient and the Public Sector. In the case that any health provider intends to use the negotiated preferential pricing as the basis of a for-profit model, then the profit margin should always result in an affordable price. As a rule-of-thumb, in the for-profit model, the mark-up, not including transportation charges and insurance should not exceed 20% of the negotiated preferential price. If this is not the case, then the preferential prices shall no longer automatically apply. Any proposed exceptions to this rule-of-thumb require discussion and agreement with the manufacturer.
The public sector in eligible countries is defined as:
- Governments or government-funded institutions such as Ministry of Health, associated hospitals, armed forces, prison services in those countries;
- NGOs and UN-related organizations working for or in those countries such as International Organization for Migration (IOM) and UNICEF;
- Not-for-profit organizations such as Médecins Sans Frontières, Save-the-Children, OXFAM and the International Committee of the Red Cross (ICRC);
- Funding mechanisms such as GDF, UNITAID, PEPFAR, USAID, Global Fund, etc. and agencies based outside the country but who are supporting implementation locally in the country, such as the USA-CDC and The Union.
Private organizations recognized by the local Ministry of Health, whose mission is in line with humanitarian principles such as private charities and/or private hospitals and clinics, decided on a case-by-case basis by the manufacturer in consultation with local and global stakeholders.